These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 7606777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM, Heitman J, Cardenas ME.
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [Abstract] [Full Text] [Related]

  • 4. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
    Helliwell SB, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R, Hall MN.
    Mol Biol Cell; 1994 Jan; 5(1):105-18. PubMed ID: 8186460
    [Abstract] [Full Text] [Related]

  • 5. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
    Cardenas ME, Heitman J.
    EMBO J; 1995 Dec 01; 14(23):5892-907. PubMed ID: 8846782
    [Abstract] [Full Text] [Related]

  • 6. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
    Stan R, McLaughlin MM, Cafferkey R, Johnson RK, Rosenberg M, Livi GP.
    J Biol Chem; 1994 Dec 23; 269(51):32027-30. PubMed ID: 7528205
    [Abstract] [Full Text] [Related]

  • 7. Missense mutations at the FKBP12-rapamycin-binding site of TOR1.
    Freeman K, Livi GP.
    Gene; 1996 Jun 12; 172(1):143-7. PubMed ID: 8654975
    [Abstract] [Full Text] [Related]

  • 8. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
    Alarcon CM, Cardenas ME, Heitman J.
    Genes Dev; 1996 Feb 01; 10(3):279-88. PubMed ID: 8595879
    [Abstract] [Full Text] [Related]

  • 9. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
    Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT.
    J Biol Chem; 1995 Jan 13; 270(2):815-22. PubMed ID: 7822316
    [Abstract] [Full Text] [Related]

  • 10. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL.
    Nature; 1994 Jun 30; 369(6483):756-8. PubMed ID: 8008069
    [Abstract] [Full Text] [Related]

  • 11. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
    Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, Faucette L, Eng WK, Johnson RK, Livi GP.
    Mol Cell Biol; 1993 Oct 30; 13(10):6012-23. PubMed ID: 8413204
    [Abstract] [Full Text] [Related]

  • 12. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
    Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P, Hall MN.
    Mol Cell; 2002 Sep 30; 10(3):457-68. PubMed ID: 12408816
    [Abstract] [Full Text] [Related]

  • 13. TOR controls translation initiation and early G1 progression in yeast.
    Barbet NC, Schneider U, Helliwell SB, Stansfield I, Tuite MF, Hall MN.
    Mol Biol Cell; 1996 Jan 30; 7(1):25-42. PubMed ID: 8741837
    [Abstract] [Full Text] [Related]

  • 14. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
    Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN.
    Cell; 1993 May 07; 73(3):585-96. PubMed ID: 8387896
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.
    Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RT.
    Prog Cell Cycle Res; 1995 May 07; 1():53-71. PubMed ID: 9552353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine.
    Weisman R, Choder M.
    J Biol Chem; 2001 Mar 09; 276(10):7027-32. PubMed ID: 11096119
    [Abstract] [Full Text] [Related]

  • 19. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity.
    Sabatini DM, Pierchala BA, Barrow RK, Schell MJ, Snyder SH.
    J Biol Chem; 1995 Sep 08; 270(36):20875-8. PubMed ID: 7673106
    [Abstract] [Full Text] [Related]

  • 20. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
    Chiu MI, Katz H, Berlin V.
    Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12574-8. PubMed ID: 7809080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.